Artificial intelligence and multi-omics nominate TAZ as an insomnia-related diagnostic and druggable target for Parkinson's disease patients
{{output}}
Background: Insomnia is one of the most common non-motor comorbidities of Parkinson's disease (PD) and often before the onset of motor symptoms. Identifying the molecular mechanisms of insomnia may facilitate the early diagnosis... ...
